期刊文献+

MicroRNA在子宫内膜癌发生、发展及临床诊治中的研究 被引量:7

Research of endometrial cancer occurrence,development,clinical diagnosis and treatment-related microRNA
下载PDF
导出
摘要 microRNA是一种内源性的大小在20 nt左右的一类非编码RNAs,其通过下调靶基因的表达或翻译而参与调节细胞的发育、增殖、分化、凋亡。近期研究发现microRNA具有癌基因和抑癌基因的作用,已发现miR-21,miR-200c,miR-205,MiR-125b,miR-194等与子宫内膜癌的发生、发展、侵袭及转移相关,miRNA-200家族则参与子宫内膜癌的耐药机制。对其相应的调控机制和靶基因PTEN,TP53INP1,BMI-1,AP-2α等的研究也已有了一些进展,为子宫内膜癌的研究开辟了一条新途径。本文就子宫内膜癌相关Micro RNA的研究进展予以综述。 microRNA are endogenous non-coding RNAs about 20 nt that can play important regulatory roles in de- velopment,proliferation, diferentiation and apoptosis with respect to cells by negatively controlling expression or trans- lation on target mRNA. Recent studies indicate that microRNA can function as both oncogene and anti-oncogene. miR-21, miR-200c, miR-205, MiR-125b, miR-194 etc, have been demonstrated to be related with tumorigenesis, de- velopment, invasiveness and metastasis, while miR-200 are regarded to be correlated with multidrug resistance in en- dometrial cancer. There are already much advancement in research of the regulatory mechanism and target genes, as PTEN, TP53INP1, BMI-1, AP-2ct and so forth, which might provide a new way in studying endometrial cancer. This article reviewed the research advancement about microRNA in endometrial cancer.
出处 《中国医药导报》 CAS 2013年第6期30-32,共3页 China Medical Herald
基金 国家自然基金资助项目(项目编号:30772317)
关键词 MICRORNA 子宫内膜癌 癌基因 抑癌基因 肿瘤 microRNA Endometrial cancer Oncogene Anti-oncogene Tumor
  • 相关文献

参考文献20

  • 1Marsh EE,Lin Z,Yin P,et al. Differential expression of micro RNA species in human uterine leiomyoma versus normal myometrium [J]. Fertil Steri!, 2008,89 (6) : 1771-1776.
  • 2Bartel DP. microRNAs : genomics ,biogenesis, mechanism, and function [J]. Cell ,2004,16(2) :281-297.
  • 3Lee RC,Feinbaum RL,Ambros V,et al. Elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 [J]. Cell, 1993,75(5) :843-854.
  • 4Reinha BJ,Slack FJ, Bassou M,et al. The 21-nucleotidelet, 7 RNA regulates developmental timing in Caenorhabditis elegans [J]. Nature, 2000,403 (6772) : 901-906.
  • 5Griffiths JS,Grocock RJ,Van DS,et al. miRBase:mieroRNA se- quences,targets and gene nomenclature [J]. Nucleic Acids Res, 2006,34 ( Database issue ) : D 140-D 144.
  • 6Winter J,Jung S,Keller S,et al. Many roads to maturity:microRNA biogenesis pathways and their regulation [J]. Nat Cell Biol,2009,11 (3), 228-234.
  • 7Cashew RW,Sontheimer EJ. Origins and Mechanisms of miRNAs and siRNAs [J]. Cell,2009, 136(4) :642-655.
  • 8Inui M ,Martello G,Piccolo S. MicroRNA control of signa transduction [J]. Nat Rev Mol Cell Bio1,2010,11 (4) :252-263.
  • 9沈月兰,蒋义国.microRNA与癌症发生相关性研究的现状[J].中华肿瘤防治杂志,2008,15(1):68-71. 被引量:31
  • 10Perron MP,Provost P. Protein interactions and complexes in human microRNA biogenesis and function [J]. Front Biosci,2008,13: 2537-2547.

二级参考文献25

  • 1杜秋丽.miRNA及其功能研究[J].生物学通报,2004,39(8):13-15. 被引量:9
  • 2Barrel D P, Chen C Z. Micromanagers of gene expression:The potentially widespread influence of metazoan microRNA[J]. Nat Rev Genet,2004,5(5) :396-400.
  • 3Cimmino A, Calin G A, Fabbri M, et al. MiR 15 and miR-16 induce apoptosis by targeting BCL2[J]. Proc Natl Acad Sci U S A, 2005,102(39) :13944-13949.
  • 4He H,Jazdzewski K,Li W,et al. The role of microRNA genes in papillary thyroid carcinoma[J]. PNAS, 2005,102(52) : 19075- 19080.
  • 5Caldas C, Brenton J D. Sizing up miRNA as cancer genes[J]. Naure Med,2005,11(7) :712-714.
  • 6Calin G A,Ferracin M,Cimmino A,et al. A microRNA signaure associated with prognosis and progression in chronic lymphocytic leukemia[J]. N EnglJ Med,2005,353(17),1793-1801.
  • 7Chen C Z,Lodish H F. MicroRNAs as regulators of mammalian hematopoiesis[J]. Semin Immunol,2005,17(2) : 155- 165.
  • 8Hayashita Y, Osada H, Tatematsu Y,et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation[J]. Cancer Res,2005,65 (21) :9628-9632.
  • 9Bartel D P. MicroRNAs: Genomics, biogenesis, mechanism and function[J]. Cell,2004,116(2) :281-297.
  • 10Lee R C, Feinbaum R L, Ambros V. The C. elegans hetero chronic gene lin 4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell,1993,75(5) :843-854.

共引文献30

同被引文献80

  • 1吴传勇,薛剑,娄加陶.microRNA在肺癌诊断、治疗及预后判断中的作用[J].上海交通大学学报(医学版),2011,31(3):368-372. 被引量:7
  • 2胡莉.PTEN和P53在子宫内膜癌中的表达及意义[J].中国老年学杂志,2014,34(11):2937-2939. 被引量:2
  • 3StSrkel S, Eble Jbl, Adlakha K, et al. Classification of renal cell carcinoma : Workgroup No. 1. Union lntemationale Contre le Cancer ( UICC ) and the American Joint Committee on Cancer ( AJCC ) [ J ] . Cancer, 1997, 80 ( 5 ) : 987-989.
  • 4Makhov PB, Golovine KV, Kutikov A, et al. Reversal of epigenetic silencing of AP-2alpha results in increased Zinc uptake in DU-145 and LNCaP prostate cancer cells[ J ]. Carcinogenesis, 2011, 32( 12 ): 1773-1781.
  • 5Chen C, Guo L, Shi M, et al. Modulation of IFN- ~/ receptor 1 expression by AP-2 ct influences IFN- T sensitivity of cancer cells [J] .Am J Pathol, 2012, 180 (2): 661-671.
  • 6Knight RD, Nair S, Nelson SS, et al. Lockjaw encodes azebrafish ffap2a required for early neural crest development [ J ] . Development, 2003, 130 ( 23 ) : 5755-5768.
  • 7Knight RD, Javidan Y, Zhang T, et al. AP2-dependent signals from the ectoderm regulate craniofacial development in the zebrafish embryo [ J ]. Development, 2005, 132 ( 13 ) : 3127-3138.
  • 8Oya M, Mikami S, Mizuno R, et al. Differential expression of activator protein-2 isoforms in renal cell carcinoma [ J ] . Urology, 2004, 64 ( 1 ) : 162-167.
  • 9Ropponen KM, Kellokoski JK, of transcription factor AP-2 Pirinen RT, et al. Expression in colorectal adenomas and adenocarcinomas ; comparison of immunohistochemistry and in situ hybridisation [ J ]. J Clin Pathoi, 2001, 54 ( 7 ) : 533-538.
  • 10Zeng YX, Somasundaram K, E1-Deiry WS. AP2 inhibits cancer cell growth and activates p21WAF1/CIPI expression [ J ] . Nat Genet, 1997. 15 ( 1 ) : 78-82.

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部